1-7 of 7
Dan Kaufman
Close
Sort by
Journal Articles

Development of Novel Lipid Nanoparticles and Virus-like Particles for In Vivo Engineering of Immune Cells for Targeted Cancer Therapy

Jesus Beltran-Garcia, Sangwoo Han, Barbara S. Perez, Jonathan Gunn, Ester Kwon, Dan Kaufman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3632.
https://doi.org/10.1182/blood-2023-184312
Published: 2023
Journal Articles

Engineering Human Induced Pluripotent Stem Cells with Novel Chimeric Antigen Receptors to Generate Natural Killer (NK) Cell Cancer Immunotherapies with Targeted Anti-Tumor Activity

Ye Ethan Ethan Li, MD, David Hermanson, PhD, Branden Moriarity, PhD, Ryan Bjordahl, PhD, Sajid Mahmood, PhD, Bahram Valamehr, PhD, Dan Kaufman, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1905.
https://doi.org/10.1182/blood.V130.Suppl_1.1905.1905
Published: 2017
Journal Articles

Clinical Translation of Pluripotent Cell-Derived Off-the-Shelf Natural Killer Cell Cancer Immunotherapy

Frank Cichocki, Ryan Bjordahl, PhD, Svetlana Gaidarova, Paul Rogers, Raedun Clarke, PhD, Brian Groff, Stacey Moreno, Ramzey Abujarour, PhD, Megan Robinson, Greg Bonello, PhD, Tom Lee, PhD, Weijie Lan, PhD, Betsy Rezner, BS, Stewart Abbot, Darin Sumstad, MLS, Bruce Blazar, MD, Daniel Shoemaker, PhD, Scott Wolchko, Dan Kaufman, MD, David H. McKenna, MD, Bahram Valamehr, PhD, Sarah Cooley, MD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 656.
https://doi.org/10.1182/blood.V130.Suppl_1.656.656
Published: 2017
Journal Articles

Genetically Engineered Pluripotent Cell-Derived Natural Killer Cell Therapy Provides Enhanced Antibody Dependent Cellular Cytotoxicity Against Hematologic Malignancies and Solid Tumors in Combination with Monoclonal Antibody Therapy

Huang Zhu, PhD, Ryan Bjordahl, PhD, Svetlana Gaidarova, Paul Rogers, Robert Blum, Dan Kaufman, MD, Bruce Walcheck, PhD, Bahram Valamehr, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4452.
https://doi.org/10.1182/blood.V130.Suppl_1.4452.4452
Published: 2017
Journal Articles

Engineering Human Pluripotent Stem Cell-Derived Natural Killer Cells to Prevent CD16a Shedding for Enhanced Anti-Tumor Killing

Robert Blum, MS, Aadithya Arumugam, PhD, Jianming Wu, DVM, PhD, Bruce Walcheck, PhD, Dan Kaufman, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1336.
https://doi.org/10.1182/blood.V128.22.1336.1336
Published: 2016
Journal Articles

Single-Cell Resolution of Human Pluripotent Stem Cell Derived Hemato-Endothelial Cells Reveals Distinct Transcriptional Signatures of Hemogenic Endothelium

Mathew Angelos, Juan Abrahante, Dan Kaufman, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3869.
https://doi.org/10.1182/blood.V128.22.3869.3869
Published: 2016
Journal Articles

Central nervous system acute lymphoblastic leukemia: role of natural killer cells

Liron Frishman-Levy, Avishai Shemesh, Allan Bar-Sinai, Chao Ma, Zhenya Ni, Shahar Frenkel, Vera Muench, Hilke Bruckmueller, Christian Vokuhl, Klaus-Michael Debatin, Cornelia Eckert, Martin Stanulla, Martin Schrappe, Kerry S. Campbell, Ron Loewenthal, Denis M. Schewe, Jacob Hochman, Lueder H. Meyer, Dan Kaufman, Gunnar Cario, Angel Porgador, Shai Izraeli
Journal: Blood
Blood (2015) 125 (22): 3420–3431.
https://doi.org/10.1182/blood-2014-08-595108
Published: 2015
Includes: Supplemental data